About this trial
This study aims to develop advanced artificial intelligence (AI) models that predict neonatal risks and complications based on historical multimodal health data, including ultrasound and MRI scans. The objective is to empower clinicians and provide clear, compassionate support for families navigating complex prenatal diagnoses.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Historical, de-identified neonatal records including ultrasound images, MRI scans, and clinical documentation available for analysis.
Disqualifiers
Cases with incomplete or missing critical data elements required for AI model analysis.
Trial population
The population includes retrospective, anonymized neonatal records obtained from clinical datasets, focusing on neonates previously diagnosed or assessed for congenital anomalies and neonatal risks.
Trial design
Cohort
Retrospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Accuracy of AI Model Predictions for Neonatal Risk
Evaluate the accuracy of DenseNet121-based AI models in predicting neonatal risks and congenital anomalies, measured by sensitivity, specificity, and overall prediction accuracy.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: